Drug Database
Back to search

Poland· PL-100468412

Condromed

A chondroitin sulfate product containing chondroitini natrii sulfas, registered in Poland by IBSA Farmaceutici Italia S.r.l.. The same ATC class is registered in 5 of our 19 countries.

ATC M01AX25

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedCondromedATCM01AX25REGISTER NO.PL-100468412PACKS LISTED2CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about chondroitini natrii sulfasAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Chondroitin sulfate is registered in 5 of 19 countries.

Countries holding a registration under ATC M01AX25 (chondroitin sulfate), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 4 of them publish a price we can compare per daily dose
Search chondroitin sulfate products by name

Chondroitin sulfate · ATC M01AX25

5 / 19 countries

  • Czechiaprice
  • Finlandprice
  • Japan
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Chondroitini natrii sulfas
Manufacturer
IBSA Farmaceutici Italia S.r.l.
Country
Poland (PL)
ATC code
M01AX25
ATC class
Chondroitin sulfate
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 2

  • gtin
    08053689861600
  • gtin
    08053689861594

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

3 interactions on record for chondroitin sulfate.

Graded by severity as the source publishes them — 2 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check chondroitin sulfate against other medicinesHow interaction checks work

Chondroitin sulfate · interactions on record

3 records

  • 2 moderate

Most severe, free to view

  • DicoumarolB01AA01moderate
  • WarfarinB01AA03moderate

1 more interaction with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Chondroitin sulfate in 10 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All chondroitin sulfate products

Authorised across Europe · EMA

The same active substance is authorised in 20 EEA countries. Names it is sold under:

  • Austria · Cartexan, Condrosulf
  • Belgium · Hirudoid
  • Czechia · Condrodin, Condrosulf
  • Germany · Hirudoid, Hirudoid Forte
  • Denmark · Hirudoid
  • Spain · Condrodin, Condroitín Sulfato Kern Pharma
  • Finland · Cartexan, Cartexan Laboratorio Reig Jofre, S.A.
  • France · Chondrosulf, Chondrosulf Sans Sucre Édulcoré Au Xylitol
  • United Kingdom (Northern Ireland) · Hirudoid, Hirudoid Gel
  • Greece · Condromed
  • Hungary · Cartexan, Condrosulf
  • Iceland · Hirudoid
  • Italy · Condral, Condrosulf
  • Luxembourg · Hirudoid
  • Netherlands · Hirudoid
  • Norway · Hirudoid
  • Portugal · Hirudoid, Ossin
  • Romania · Hirudoid
  • Sweden · Hirudoid
  • Slovakia · Condrosulf, Hirudoid Forte

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/bbcfe547-5891-4096-a918-2ea47e63edb4
GET /v1/drugs/bbcfe547-5891-4096-a918-2ea47e63edb4?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki",
  "source": "urpl",
  "strength": "800 mg",
  "packaging": "08053689861594 ¦ Rp ¦ 160810\n30 tabl.\n08053689861600 ¦ Rp ¦ 160811\n90 tabl.",
  "substance": "Chondroitini natrii sulfas 800 mg",
  "common_name": "Chondroitini natrii sulfas",
  "pl_product_id": "100468412",
  "pozwolenie_nr": "28900",
  "auth_procedure": "DCP",
  "authorisation_validity": "2030-03-03"
}
API referenceMCP serverPlans

See everything about chondroitin sulfate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console